CCM
HAE icon

Cullen Capital Management’s Haemonetics HAE Stock Holding History

Cullen Capital Management’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-4,143
Closed -$343K – 213
2024
Q2 		$343K Sell
4,143
-1,554
-27% -$137K ﹤0.01% 178
2024
Q1 		$486K Sell
5,697
-347
-6% -$27.2K 0.01% 150
2023
Q4 		$517K Sell
6,044
-1,078
-15% -$93.2K 0.01% 159
2023
Q3 		$638K Sell
7,122
-4,038
-36% -$361K 0.01% 125
2023
Q2 		$950K Sell
11,160
-381
-3% -$32.2K 0.01% 200
2023
Q1 		$955K Buy
11,541
+2,130
+23% +$172K 0.01% 187
2022
Q4 		$740K Sell
9,411
-6,256
-40% -$503K 0.01% 148
2022
Q3 		$1.16M Sell
15,667
-317
-2% -$22.8K 0.01% 183
2022
Q2 		$1.04M Hold
15,984
– – 0.01% 187
2022
Q1 		$1.01M Hold
15,984
– – 0.01% 185
2021
Q4 		$848K Buy
15,984
+2,805
+21% +$171K 0.01% 194
2021
Q3 		$930K Sell
13,179
-136
-1% -$8.58K 0.01% 172
2021
Q2 		$887K Buy
+13,315
New +$942K 0.01% 180

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $59.5B AUM 35.96% 1-Year Est. Return

Cullen Capital Management's HAE Position: Q3 2024 in Review

Cullen Capital Management sold out of Haemonetics (HAE) in Q3 2024, closing a stake of 4,143 shares — an estimated $343K sold.

Cullen Capital Management first reported a position in HAE in Q2 2021 and held it in 13 quarters. The position peaked at $1.16M in Q3 2022. 306 funds tracked by Wall St. Rank hold HAE as of Q3 2024.

  • Cullen Capital Management reported no remaining Haemonetics position as of Q3 2024 after selling out during the quarter.
  • Cullen Capital Management sold 4,143 Haemonetics shares in Q3 2024, an estimated $343K.
  • Cullen Capital Management first reported a position in Haemonetics in Q2 2021 and held it in 13 quarters.
  • Cullen Capital Management's Haemonetics position peaked at $1.16M in Q3 2022.
  • 306 funds tracked by Wall St. Rank held Haemonetics as of Q3 2024.

Based on Cullen Capital Management's 13F filing for Q3 2024, filed 12 Nov 2024.